Randomized phase 3 study of rituximab, cyclophosphamide, doxorubicin, and prednisone plus vincristine (R-CHOP) or bortezomib (VR-CAP) in newly diagnosed.
The IBCSG August 2007. History of IBCSG In January 1976, Dr Jan Stjernswärd invited: Kurt Brunner, John Forbes, Percy Helman, Carl- Magnus Rudenstam,
